FDA Strikes Off European Biotech Pharming’s Immune Deficiency Drug For Expanded Use In Pediatric Patients

All NewsFebruary 2, 2026

FDA issued a CRL to Pharming’s Joenja child use filing, citing dosing concerns in lower-weight kids and testing issues.

Importance Rank:

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Manage consent